Editors:
- P?rovides a concise, but comprehensive summary of the current management of patients with atypical breast proliferative lesions
- Written by experts in the field
- Supplies assessment tools for risk prediction of breast cancer
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (13 chapters)
-
Front Matter
-
Back Matter
About this book
This book will provide a comprehensive review of this field and will serve as a valuable resource for clinicians, general surgeons, breast surgeons and surgical oncologists, as well as researchers with an interest in the management of atypical breast lesions. The book will review new data about breast cancer, risk factors for breast cancer, pathological features unique to each entity, the characteristic findings on imaging, risk stratification for genetic testing, as well as the current evidence-based management of each of these breast lesions. Our text will provide assessment tools for risk prediction of breast cancer. We will provide data on thecurrent imaging modalities, as well as advanced screening options available for diagnosis and following these patients. Current management of many of these lesions continues to be controversial in regard to observation with close surveillance versus the need for surgical excision of these lesions based on future risk or whether these lesions are precursor lesion. For ductal carcinoma in-situ, the debate continues in regards to whether this disease entity is a precursor lesion that can be managed with observation or hormonal therapy, or is DCIS cancer and treated with lumpectomy and radiation. Several studies have been published where patients are managed with observation and treatment with hormonal therapy before surgical management. New trials have already begun accruing patients with low to intermediate grade DCIS where patients will be managed with observation versus hormonal therapy only. Management of DCIS continues to evolve and current management will be discussed
This text will provide a concise but comprehensive summary of the current management of patients with atypical breast proliferative lesions and some benign breast lesions and will help guided management of these patients. All chapters in this text will be written by experts in the field in each of these disease entities. They will all include the most up to date research and clinical information to enhance our understanding and treatment of patients.
Editors and Affiliations
-
Samuel Oschin Comprehensive Cancer Inst, Cedars-Sinai Medical Center, Los Angeles, USA
Farin Amersi
-
School of Medicine, University of Washington School of Medicine, Seattle, USA
Kristine Calhoun
About the editors
Associate Professor of Surgery
Cedars-Sinai Medical Center
Samuel Oschin Comprehensive Cancer Institute
8700 Beverly Blvd, #AC1046A
Los Angeles, CA, 90048, USA
Kristine Calhoun, MD
Associate Professor of Surgery
University of Washington School of Medicine
Associate Director, Breast Health Clinic, Seattle Cancer Care Alliance
1959 NE Pacific Street, Box 356410
Seattle, WA, 98195, USA
Bibliographic Information
Book Title: Atypical Breast Proliferative Lesions and Benign Breast Disease
Editors: Farin Amersi, Kristine Calhoun
DOI: https://doi.org/10.1007/978-3-319-92657-5
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing AG, part of Springer Nature 2018
Hardcover ISBN: 978-3-319-92656-8Published: 10 October 2018
Softcover ISBN: 978-3-030-06482-2Published: 19 January 2019
eBook ISBN: 978-3-319-92657-5Published: 27 September 2018
Edition Number: 1
Number of Pages: XI, 197
Number of Illustrations: 4 b/w illustrations, 24 illustrations in colour
Topics: General Surgery, Surgical Oncology, Oncology, Pathology